GVR Report cover Bone Allografts Market Size, Share & Trends Report

Bone Allografts Market Size, Share & Trends Analysis Report By Application (Dental, Spine), By End-use (Hospitals & Dental Clinics, Orthopedic & Trauma Centers), By Type (Cancellous, Cortical), And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-968-4
  • Number of Pages: 130
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Report Overview

The global bone allografts market size was valued at USD 1.6 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 9.0% from 2022 to 2030. The growing geriatric population, rising healthcare costs, and rising healthcare provider adherence to allograft are some of the factors propelling the industry's growth. Other factors include the rising number of surgical procedures, such as joint reconstruction and spinal fusion surgeries. In addition, during the forecast period, the development of sophisticated bone graft procedures and an increase in the frequency of bone fractures are anticipated to propel the expansion of the market.

North America bone allograft market size, by type, 2020 - 2030 (USD Billion)

However, several obstacles are limiting the growth of the industry, including the high cost of bone graft techniques, a lack of reimbursement, the availability of bone graft replacements, and a shortage of experienced specialists. The COVID-19 pandemic had a negative impact on the global industry, resulting in poor demand and sales. The pandemic resulted in a considerable decrease in procedure volumes in 2020, which hampered the growth. The cancellation or postponement of elective surgeries during the epidemic had a significant influence on the industry. In addition, numerous hospitals & dental clinics, and specialist centers were converted into COVID-19 treatment centers, reducing the number of treatments even more.

For example, the Hospital for Special Surgery (HSS) Spine Care Institute is a musculoskeletal therapy center specializing in specialist care. All elective surgeries, including spine surgeries, were postponed between March 17 and June 8, 2020, and the hospital was transformed into a recognized COVID-19 treatment facility. As a result, such variables have a detrimental impact on industry growth. Many emerging nations’ healthcare reforms are extending treatment access to a larger proportion of their people, which is expected to stimulate the demand for healthcare-related products, particularly spinal surgery products. Increasing economic affluence in major developing regions would boost demand for such products, resulting in industry expansion.

Some of the key drivers impacting the industry include an aging population and the growing adoption of allografts due to their properties, such as immediate structural support and osteoconductivity. In addition, they do not require another surgery bone, which triggers fast wound healing and decreases the surgery time. These are commonly used in dental, spine, and hip areas. Furthermore, demineralized bone matrices are easily available in various sizes and shapes, such as chips, pellets, and granules. Moreover, they demonstrate both osteoinductive as well as osteoconductive properties, which increases their popularity, hence boosting the industry growth.

Type Insights

On the basis of types, the global industry has been further sub-segmented into demineralized bone matrices, and cortical, cancellous, & corticocancellous bone allografts. The demineralized bone matrix segment dominated the industry in 2021 and accounted for the maximum share of more than 35.75% of the total revenue. A demineralized bone matrix is a form of bone allograft utilized in bone defects and spinal fusion. The segment is anticipated to see growth throughout the forecast period, due to factors such as rising frequency of orthopedic ailments, rising spinal fusion & dental surgery cases, and rising patient base due to population growth.

For a variety of purposes, including treating bone and joint diseases, the demineralized bone matrix is frequently employed in orthopedic procedures. The demand is expected to increase due to a rise in orthopedic problems brought on by weakening bones. The population of individuals aged over 60 years was 900 million in 2015, and the World Health Organization’s (WHO) population division predicts that this number will increase to 2 billion by 2050. As a result, the rising prevalence of orthopedic problems and the growing geriatric population will support the growth.

Application Insights

On the basis of applications, the global industry has been further sub-segmented into dental, spine, reconstruction & traumatology, and others. The reconstruction & traumatology application segment is estimated to register the fastest growth rate of more than 9.2% during the forecast period. The dental application segment dominated the global industry in 2021 and accounted for the maximum share of the overall revenue. The dental segment is estimated to expand further at the second-fastest growth rate, maintaining its dominant position in the market throughout the forecast period.

The primary driver fueling the segment expansion is the rising use of bone grafts in dental implant procedures. In addition, the increasing frequency of periodontal disorders, root caries, and edentulous support the growth. In addition, the ongoing commercialization of products, growing healthcare industry, and high-quality services are increasing consumer awareness and are anticipated to support market expansion. Furthermore, the rising success rate of these operations will support the growth. It is also anticipated that the expanding dental tourism industry in developing nations will drive industry expansion. The introduction of new products will also accelerate future growth.

End-use Insights

On the basis of end-uses, the global industry has been further sub-segmented into hospitals & dental clinics, orthopedic & trauma centers, and others. The hospitals & dental clinics end-use segment dominated the global industry and accounted for the largest share of more than 44.50% of the overall revenue in 2021. The high share of this segment can be attributed to the fact that most facilities and technologically advanced implants are available in hospitals & dental clinics for treating & diagnosing spine disorders. With the growing demand for bone grafts for patients with spine disorders and dental pain, the segment is estimated to witness steady growth.

Global bone allografts market share, by end-use, 2021 (%)

The orthopedics and trauma centers end-use segment, on the other hand, is estimated to register the fastest growth rate during the forecast years. These centers provide end-to-end care and management for all types of bone and joint disorders. Many patients experience less pain in their daily activities as a result of these centers' professional and individualized surgical approach to bone and joint disorders. Furthermore, surgeons at these centers are highly specialized, combining decades of experience with cutting-edge research to provide the best possible care.

Regional Insights

The North America region dominated the global industry in 2021 and accounted for the maximum share of more than 39.00% of the global revenue. Growing awareness related to the commercially accessible innovative products, accessibility to a well-developed healthcare structure, and higher healthcare expenditure, are the major aspects contributing to the regional growth. For instance, the amount spent on healthcare increased to $4.1 trillion by 2020 from an estimated $1.4 trillion in 2000. Compared to the 4.3 % growth from 2018 to 2019, health spending climbed by 9.7% between 2019 and 2020.

Bone Allografts Market Trends by Region

Furthermore, the market in the U.S. is leading the North American as well as the global industry by generating the maximum product demand, as a result of the growing number of trauma-related injuries as well as cases of orthopedic diseases. Europe is estimated to advance at the fastest CAGR from 2022 to 2030. The increasing global geriatric population is one of the key factors driving the artificial disc industry. The improvement in quality of life and total life expectancy was largely attributed to improvements in health facilities and disposable money. The geriatric population makes up a sizable portion of the subpopulation that is vulnerable to several diseases and disorders, including degenerative spine diseases.

Key Companies & Market Share Insights

The industry is competitive and fragmented. Leading companies are involved in deploying strategic initiatives that include product launches, service expansion, competitive pricing strategies, sales & marketing initiatives, partnerships, and mergers & acquisitions. For instance, a functional cellular bone allograft called MAGNUS was introduced by Royal Biologics in January 2020. MAGNUS uses a new generation of DMSO-free cryoprotectants to retain viable spine-derived cells that are extracted from a donor’s vertebral body. Some of the key players in the global bone allografts market include:

  • Zimmer Biomet

  • Medtronic

  • Lynch Biologics, LLC

  • Biomatlante

  • Stryker

  • Royal Biologics

  • Johnsons & Johnsons

  • Smith & Nephew

  • Baxter

  • Xtant Medical

Bone Allografts Market Report Scope

Report Attribute

Details

The market size value in 2022

USD 1.7 billion

The revenue forecast in 2030

USD 3.5 billion

Growth rate

CAGR of 9.0% from 2022 to 2030

Base year for estimation

2021

Actual estimates/Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million/billion and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, application, end-use, region

Regions covered

North America; Europe; Asia Pacific; Latin America; MEA

Country Scope

U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia

Key companies profiled

Zimmer Biomet; Medtronic; Lynch Biologics, LLC; Biomatlante; Stryker; Royal Biologics; Johnsons & Johnsons; Smith & Nephew; Baxter

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Global Bone Allografts Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global bone allografts market report on the basis of type, application, end-use, and region:

Global Bone Allografts Market Segmentation

  • Type Outlook (Revenue, USD Million, 2017 - 2030)

    • Cortical Bone Allografts

    • Cancellous Bone Allografts

    • Corticocancellous Bone Allografts

    • Demineralized bone Matrices

  • Application Outlook (Revenue, USD Million, 2017 - 2030)

    • Dental

    • Spine

    • Reconstruction & Traumatology

    • Others

  • End-use Outlook (Revenue, USD Million, 2017 - 2030)

    • Hospitals & Dental Clinics

    • Orthopedic and Trauma Centers

    • Others

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.